NFATC3 and cardiac hypertrophy: Thus, parts of pathologic cardiac hypertrophy ameliorated by 25-OH-D3 can be attributed to relieved calcineurin-NFAT4c signaling and MHC-β expression due to a decrease of mechanical loading and angiotensin stimulation [23].